Source:http://linkedlifedata.com/resource/pubmed/id/12591095
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2003-2-19
|
pubmed:abstractText |
A synthetic ceramide analog, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (L-PDMP) upregulates ganglioside biosynthesis in several cell lines. In cultured cortical neurons, neurotrophic effects of L-PDMP on neurite outgrowth and synaptic activity were demonstrated. In addition, it was found that L-PDMP could ameliorate the spatial cognition deficit in rats with ischemia. To elucidate this effect, we evaluated the effect of L-PDMP on brain ganglioside biosynthesis and its therapeutic efficacy against spatial cognition deficit in rats made ischemic. Rats were trained for 2 weeks, using an 8-arm radial maze task, and then forebrain ischemia was induced. L-PDMP was injected i.p. at 40 mg/kg twice a day starting from day 1 or 3 after ischemia induction for 6 or 4 days, respectively. The first study showed significantly reduced spatial cognition deficit at 12 h after the final drug administration, and L-PDMP tended to attenuate apoptosis in hippocampal CA1. To examine the effect of L-PDMP on brain ganglioside biosynthesis, N-[3H]acetyl-D-mannosamine was infused into the lateral ventricle via an injection cannula at 12 h after the final drug administration. After 4 h, the brain gangliosides were purified and analyzed. Upregulation of ganglioside biosynthesis by L-PDMP was observed on days 3 and 5 after ischemia. These results are an indication that L-PDMP may ameliorate spatial cognition deficit by upregulating ganglioside biosynthesis in ischemic brain.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
462
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-60
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12591095-Animals,
pubmed-meshheading:12591095-Apoptosis,
pubmed-meshheading:12591095-Brain,
pubmed-meshheading:12591095-Brain Ischemia,
pubmed-meshheading:12591095-Cerebral Cortex,
pubmed-meshheading:12591095-Cognition,
pubmed-meshheading:12591095-Cognition Disorders,
pubmed-meshheading:12591095-Gangliosides,
pubmed-meshheading:12591095-Hippocampus,
pubmed-meshheading:12591095-Male,
pubmed-meshheading:12591095-Maze Learning,
pubmed-meshheading:12591095-Morpholines,
pubmed-meshheading:12591095-Neurons,
pubmed-meshheading:12591095-Rats,
pubmed-meshheading:12591095-Rats, Wistar,
pubmed-meshheading:12591095-Spatial Behavior
|
pubmed:year |
2003
|
pubmed:articleTitle |
A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia.
|
pubmed:affiliation |
Department of Neuropharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1, Nanakuma, Jonan, Fukuoka 814-80, Japan.
|
pubmed:publicationType |
Journal Article
|